Mother of all adulteration stories! The dairy run by promoter Pomil Jain and Vipin Jain never procured a drop of milk or butter from anywhere, and yet managed to supply 68 lakh kg of ghee worth Rs 250 crores to the Trumala Tirupati Devasthanam (TTD) which runs the famous

#India | Weight loss drug Wegovy to become cheaper as Novo Nordisk cuts prices by up to 37% Viswanath Pilla with details ⬇🔗 moneycontrol.com/news/india/wei… #Wegovy #Weightloss #Novo #nordisk

Biocon CEO sees USFDA draft rules potentially slashing biosimilar development costs by half Viswanath Pilla with details ⬇🔗 moneycontrol.com/news/india/bio… #Biocon #USFDA #Pharma #Healthcare

#Business | Mankind Pharma hit by domestic slowdown, slow BSV synergy and GST 2.0, but margin guidance intact Viswanath Pilla with details ⬇🔗 moneycontrol.com/news/business/… #MankindPharma #BSVEnergy #GST

#Business | From burn to earn: API Holdings targets profitability by March FY27 under new CEO Viswanath Pilla with details ⬇🔗 moneycontrol.com/news/business/… #APIHoldings #RahulGuha #DigitalHealth

#Business | Toxic air fuels sale of respiratory drugs, segment grows 14.7% in October Viswanath Pilla with details ⬇🔗 moneycontrol.com/news/business/… #ToxicAir #Respiratory #Pollution #AirPollution #Drugs

#Business | Rainbow Hospitals targets 3,165 beds by FY29, eyes high-birth North India as key growth engine Viswanath Pilla with details ⬇🔗 moneycontrol.com/news/business/… #RainbowHospital #ChildrensHospital #NorthIndia

Cipla’s respiratory push: Sets up diagnostic centre in Delhi, Mumbai and other cities next Details by Viswanath Pilla ⤵️| #Business moneycontrol.com/news/trends/he…

“Very confident of positive outcome”: Habil Khorakiwala on USFDA acceptance of Wockhardt’s NDA for its novel antibiotic Details by Viswanath Pilla ⤵️| #Business moneycontrol.com/news/business/…

#Business | Indian pharma eyes US biosimilars boom as USFDA eases rules Viswanath Pilla with details ⬇🔗 moneycontrol.com/news/business/… #Pharma #USFDA

This man who grew up in middle class India literally built the only startup outside US/China/Japan that sent rockets to space. Here's the never-before-shared crazy story of Pawan Chandana: > be middle class kid growing up in Vizag > terrible student, get 51 marks in maths >

Aurobindo Group in mega infra push, to develop Kakinada port, SEZ as industrial-logistics hub Details by Viswanath Pilla ⤵️| #Business moneycontrol.com/news/business/…

Biocon to absorb biologics unit, eyes Rs 4,500 cr fund raise to buy Viatris’s residual stake Details by Viswanath Pilla ⤵️| #Biocon #Business moneycontrol.com/news/business/…

Mounjaro retains top spot in India’s weight-loss market; Wegovy makes steady gains after price cuts Details by Viswanath Pilla ⤵️| #Business #India moneycontrol.com/news/business/…

🚨 Would you take drugs to lose weight? The GLP-1 drug craze—led by Ozempic & Wegovy (semaglutide) and Mounjaro (tirzepatide)—is reshaping India’s fitness industry, with new packages bundling diagnostics, lifestyle coaching and doorstep drug delivery. #GLP1 #Ozempic #Wegovy

#Business | Urban elites drive GLP-1 weight loss boom; distribution deals, price cuts can change script Viswanath Pilla with details ⬇🔗 moneycontrol.com/news/business/… #UrbanElites #WeightLoss #Wegovy #Mounjaro

#Business | #NovoNordisk launches #Ozempic in India against #diabetes for Rs 2,200 per week entry dose Viswanath Pilla with details ⬇🔗 moneycontrol.com/news/business/…

#MCInterview 🚨 | Medicover’s India arm aiming for 2026 IPO to unlock value in Swedish giant’s fastest-growing market Viswanath Pilla with details ⬇🔗 moneycontrol.com/news/business/… #Medicover #IPO

#Business | For India’s weight-loss segment, 2025 is the warm-up, 2026 to be inflection point @viswanath_Pilla with details ⬇🔗 moneycontrol.com/news/business/… #Weightloss #Pharma #Healthcare

🚨💊Government bans high-dose Nimesulide oral formulations over safety concerns Viswanath Pilla reports 👇 moneycontrol.com/news/business/…